REFERENCES
- Backman U, Danielson BG, Ljunghall S. Renal stones: Etiology, management, treatment. Stockholm: Almqvist & Wiksell International, 1985.
- Chaussy Ch (ed). Extracorporeal shock wave lithotripsy. New aspects in the treatment of kidney stone disease. Basel: Karger, 1984.
- Danielson BG. Use of magnesium as prophylactic treatment of recurrent calcium stones. In:Griffith DB, ed. Controversies in urological management. Plenum Publ Corp, USA, 1984 (in press).
- Fellström B, Danielson BG, Karlström B, Lithell H, Ljunghall S, Vessby B. Urinary composition and supersaturation on a high protein diet. Contrib Nephrol 1984; 37: 27–30.
- Fellström B, Danielson BG, Ljunghall S, Wikström B. The inhibition of calcium oxalate crystal growth by chondroitin sulfates, heparin, pentosan polysulfate and Tamm-Horsfall glycoprotein. In: Proc Vth Internat Symp Urolithiasis 1984 (in press).
- Ljunghall S, Backman U, Danielson BG, Johansson G, Jung B, Källsen R, Wibell L, Wålinder O. Mechanisms of hypercalciuria in recurrent renal stone formers. Scand J Urol Nephrol 1977 41 (suppl): 77–96.
- Ljunghall S, Backman U, Danielson BG, Fellström B, Johansson G, Wikström B. Long-term treatment with bendroflumethiazide for prevention of renal stones. Clinical experiences. In:Smith LH, Robertson WG, Finlayson B, eds. Urolithiasis: Clinical and basic research. New York: Plenum Press, 1981: 241–244.
- Ljunghall S, Backman U, Danielson BG, Fellström B, Johansson G, Wikström B, Wålinder O. Experiences with long-term use of sodium cellulose phosphate (SCP) for prevention of renal calcium stones. InSmith LH, Robertson WG, Finlayson B, eds. Urolithiasis: Clinical and basic research. New York: Plenum Press, 1981: 275–282.
- Meyer JL, Thomas WC Jr. Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. I. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium phosphate crystal growth. J Urol 1982; 128: 1372–1375.
- Parsons CL. Prevention of urinary tract infection by the exogenous glycosaminoglycans sodium pentosan-polysulfate. J Urol 1982; 127: 167–169.
- Parsons CL, Danielson BG, Fellström B. Inhibition of uric acid crystal adherence by bladder surface and urinary glycosaminoglycans. J Urol (in press).
- Robertson WG, Peacock M, Marhall RW, Speed R, Nordin BEC. Seasonal variations in the composition of urine in relation to calcium stone formation. Clin Sci Mol Med 1975; 49: 597–602.
- Robertson WG, Peacock M, Heyburn PJ, Hanes FA, Quimet D, Rutherford A, Sergeant VJ. Should recurrent calcium oxalate stone formers eat less animal protein?. In:Smith LH, Robertson WG, Finlayson B, eds. Urolithiasis: Clinical and basic research. New York: Plenum Press, 1981: 359–362.
- Smith LH, Werness PG, Van den Berg CJ, Wilson DM. Orthophosphate treatment in calcium urolithiasis. Scand J Urol Nephrol 1980 53 (suppl): 253–262.
- Tew NP, Malis CD, Lehninger AL, Walker GW, Howard JE. Inhibition of PTH induced nephrocalcinosis by phosphocitrate. In:Smith LH, Robertson WG, Finlayson B, eds. Urolithiasis: Clinical and basic research. New York: Plenum Press, 1981: 559–568.